Table 1

Schedule of baseline and follow-up measures

Screening and baselineMonth 3Month 9Month 15*
Demographics (eg, age, gender, education attained, employment status)X
Self-reported cigarettes per day (or equivalent)XXXX
Reduction of ≥50% in number of cigarettes smoked since baseline†XX
Biochemically confirmed abstinence (self-reported quitters only)XXX
Self-reported floating prolonged abstinence (since quitting smoking, with quit date, if relevant) over at least 6 months†XX
Accelerometer assessed minutes of moderate and vigorous physical activity in a subsampleX
Self-reported 7-day recall of physical activityXXX
Heaviness of Smoking IndexX
Use of smoking management productsXXXX
Urge and strength of urge to smokeXX
Engagement with the health trainer intervention (8 weeks, plus optional 6 weeks additional support if a quit attempt is made)X
Health and social care utilisationXXX
Health-related quality of life (EQ-5D-5L and SF-12)XXX
Self-reported weight and height (to calculate BMI)XXX
Self-reported process measuresXX
 Importance and confidence in smoking reduction and cessation
 Importance and confidence in being physically active
 Action planning to change smoking
 Action planning to change physical activity
 Self-monitoring of smoking
 Self-monitoring of physical activity
 Availability of support to reduce smoking
 Availability of support to increase physical activity
 Use of physical activity for smoking regulation
Serious adverse events (self-reported)XX
Qualitative process evaluation (in parallel throughout) (sample)XXXX
  • *Only participants with biochemically verified abstinence at 9 months are followed-up at 15 months post-baseline.

  • †Derived measure.

  • BMI, body mass index; EQ-5D-5L, EuroQol-5 dimension-5 level ; SF-12, 12-Item Short Form Health Survey.